top of page
Drug Delivery Business News
Senseonics (NYSE:SENS) announced today that it integrated SweetSpot software with its Eversense 365 continuous glucose monitor (CGM) in the U.S.
The software integration provides endocrinology practices that partner with SweetSpot the ability to seamlessly and regularly review data from patients using Eversense 365, the world’s first and only one-year CGM.
Senseonics won FDA clearance for the Eversense 365 one-year implantable CGM. With its global distribution partner, Ascensia Diabetes Care, it announced the launch for Eversense 365 on Oct. 1. The company also said earlier this month that it submitted the system for CE mark. Read the full article here: https://www.drugdeliverybusiness.com/senseonics-diabetes-management-software-integration-eversense-365/
bottom of page